Form D · Pharmaceuticals
Somaxon Pharmaceuticals, Inc.
Solana Beach, CA · CIK 0001339455
Offering snapshot reported Jul 15, 2009 · SEC filing
- Reported sold
- $6M Offering amount: $6M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 8, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 15, 2009 | Initial | $5,999,990 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-89181
Source: Form D, filed Jul 15, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Terrell A. Cobb | Director |
| Brian T. Dorsey | Executive |
| Michael L. Eagle | Director |
| David F. Hale | Director |
| Erle T. Mast | Director |
| Matthew W. Onaitis | Executive |
| Richard W. Pascoe | Director, Executive |
| Jeffrey W. Raser | Executive |
| Jesse I. Treu | Director |
| Kurt Von Emster | Director |
| Kurt C. Wheeler | Director |
| Thomas G. Wiggans | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
420 Stevens Avenue Suite 210
Solana Beach, CA, 92075
Solana Beach, CA, 92075